July 3rd 2025
CARMAT announces the initiation of a call for public tenders (buyers or investors) as part of the receivership procedure
Paris, July 3, 2025 – 6:30 pm CEST
CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces the initiation of a call for public tenders (buyers or investors)[1] as part of the receivership procedure[2] opened on July 1, 2025.
A notice will be published in “Les Echos” French newspaper by the judiciary administrator appointed by the Versailles Economic Affairs Court[3] (AJRS – Maître Philippe Jeannerot), on July 4, 2025. The Notice will however be available in the digital version of the newspaper as early as July 3, 2025 in the evening.
People interested and willing to take part in the call for public tenders are invited to get in touch with Mr Valentin Laigneau (AJRS): valentin.laigneau@aj-rs.com
It is reminded that CARMAT’s operations carry on during the observation period, and that CARMAT continues to endeavor to provide continuous support to patients who currently benefit from its Aeson® artificial heart.
Press releases will continue to be issued regularly as the Company’s situation evolves and the proceedings progress.
[1] « Appel d’Offres (recherche de repreneurs ou d’investisseurs »)
[2] « Redressement judiciaire »
[3] « Tribunal des Affaires Economiques de Versailles (France) »